Printer Friendly

Early neuroschistosomiasis complicating Katayama syndrome.

To the Editor: Neurologic complications of schistosomiasis may occur early as well as late in the course of infection; they result when a pair of worms becomes lodged in the vasculature, and their eggs become trapped in the microcirculation of the brain or spinal cord. There, they elicit a strong inflammatory response, which causes the clinical manifestations (1-3). Magnetic resonance and computed tomographic images of the brain show nonspecific, contrast-enhancing infiltrates, which suggests brain tumors (4). Definitive diagnosis requires finding Schistosoma eggs in feces, urine, rectal biopsy specimen, or biopsy specimen of central nervous system lesions (5), while a positive antibody test result provides a probable diagnosis only. To prevent irreversible damage, early treatment with corticosteroids is essential, after which the adult worms can be eliminated with praziquantel (3,4). A high degree of suspicion is therefore needed to avoid treatment delay.

Neuroschistosomiasis has been reported in persons living near Lake Malawi, in Malawi (6). Four members of a Belgian expatriate family (both parents and 2 children, a 12-year-old boy and a 7-year-old girl) went swimming in Lake Malawi in September 1998. On the advice of a physician, they took praziquantel 2 weeks afterward as postexposure prophylaxis. Nevertheless, fever, hypereosinophilia, cough, and abdominal discomfort developed in the mother and both children 6-8 weeks after they had been swimming; these symptoms were indicative of Katayama syndrome. The father remained asymptomatic but had a moderately raised eosinophil count (760 cells/[mm.sup.3]) and tested positive for Schistosoma antibodies. Schistosoma hematobium eggs were found in feces and urine of the mother and girl. All family members tested negative for schistosomiasis on a screening visit the previous year. The boy was admitted to a Zambian hospital because of high fever, cough, and a pulmonary infiltrate. He did not improve on antimicrobial drugs given for suspected pneumonia, and a gradually worsening neurologic syndrome developed, with left-sided hemiparesis, slurred speech, and slow movements.

The boy's condition prompted repatriation [approximately equal to] 10 weeks after the exposure. On admission at the University Hospital of Antwerp, his symptoms included fever, left-sided paresis with left-sided Babinski sign, and high eosinophil count (3,080 cells/[mm.sup.3]). An ELISA for Schistosoma antibodies was weakly positive. Examination of spinal fluid showed normal cell and protein content and a slightly lowered glycorrachia. A nuclear magnetic resonance (NMR) image of the brain showed multiple, small, contrast-enhanced white matter lesions around the semiovale center (cranially from the lateral ventricles) bilaterally and in the right parietal cortex. A tentative diagnosis of acute neuroschistosomiasis was made, and the patient was given corticosteroids with praziquantel, 750 mg twice a day for 14 days. At the end of this treatment, his condition had markedly improved; discrete hemiparesis was the only residual symptom. One month later, the patient had returned to normal, apart from left leg hyperreflexia. An NMR of the brain still showed residual lesions around the semiovale centers. Ten months later, results of clinical and neurologic examinations were normal, but NMR of the brain still showed minor residual lesions around the semiovale center on the right side. During follow-up, a serologic shift (indirect hemagglutination schistosomal antibody test) was seen, and eosinophil count decreased gradually to normal (Table). Although the boy never excreted eggs, S. hematobium infection was presumptively diagnosed on the basis of active infection in his relatives and the response to treatment.

When neurologic symptoms appear soon after primary infection with Schistosoma flukes, confirming the diagnosis may prove difficult, and schistosomiasis should be suspected when the patient has bathed in potentially infected water. Furthermore, hypereosinophilia is an early warning sign, as seroconversion and egg excretion may be slower to evolve. Both elements provide sufficient circumstantial evidence to strongly suspect the diagnosis (2). In this case, the full-blown Katayama syndrome contributed to the evidence.

Praziquantel only kills adult worms and does not inactivate schistosomules, nor the miracidium inside the eggs, which will continue to elicit a damaging immunologic response for some time. Early antischistosomal treatment might, in fact, worsen symptoms (7). Because schistosomules may require up to 8 weeks to mature, early postexposure treatment with praziquantel cannot be used to forestall disease after primary infection. Furthermore, Katayama syndrome may occur as early as 3 weeks after exposure. On the other hand, withholding praziquantel until larvae have matured (8 weeks after exposure) would not prevent Katayama syndrome in many cases (7). Acute symptoms, including early neuroschistosomiasis, may therefore still develop during this 5-week window after exposure, despite early praziquantel administration.

Artemether has shown promising activity against schistosomules (8). Repeated administration throughout the transmission season has prevented Katayama syndrome in S. japonicum infection (9). Its use, singly or in combination with praziquantel, should be investigated as true postexposure prophylaxis for primary schistosomal infection in nonimmune travelers (10).

References

(1.) Pittella JE, Lana-Peixato MA. Brain involvement in hepatosplenic schistosomiasis mansoni. Brain. 1981;104:621-32.

(2.) Granier H, Potard M, Diraison P, Nicolas X, Laborde JP, Tlarmin F. Acute encephalitis concurrent with primary infection by Schistosoma mansoni. Med Trop (Mars). 2003 ;63:60-3.

(3.) Ferrari TC, Moreira PR, Cunha AS. Spinal cord schistosomiasis: a prospective study of 63 cases emphasizing clinical and therapeutic aspects. J Clin Neurosci. 2004;11: 246-53.

(4.) Silva LCS, Maciel PE, Ribas JGR, Souza-Pereira SR, Natunes CM, Lambertucci JR. Treatment of schistosomal myeloradiculopathy with praziquantel and corticosteroids and evaluation by magnetic resonance imaging: a longitudinal study. Clin Infect Dis. 2004;39:1618-24.

(5.) Nascimento-Carvalho CM, Moreno-Carvalho OA. Clinical and cerebrospinal fluid findings in patients less than 20 years old with a presumptive diagnosis of neuroschistosomiasis. J Trop Pediatr. 2004;50: 98-100.

(6.) Naus CW, Chipwete J, Visser LG, Zijlstra EE, van Lieshout L. The contribution made by Schistosoma infection to non-traumatic disorders of the spinal cord in Malawi. Ann Trop Med Parasitol. 2003;97:711-21.

(7.) Grandiere-Perez L, Ansart S, Paris L, Faussart A, Jaureguiberry S, Grivois B, et al. Efficacy of praziquantel during the incubation and invasive phase of Schistosoma hematobium schistosomiasis in 18 travelers. Am J Trop Med Hyg. 2006;74:814-8.

(8.) Xiao S, Tanner M, N'Goran EK, Utzinger J, Chollet J, Bergquist R, et al. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop. 2002;82:175-81.

(9.) Li YS, Chen HG, He HB, Hou XY, Ellis M, McManus DE A double-blind field trial on the effects of artemether on Schistosoma japonicum infection in a highly endemic focus in southern China. Acta Trop. 2005 ;96:184-90.

(10.) Utzinger J, Keiser J, Shuhua X, Tanner M, Singer BH. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother. 2003;47:1487-95.

Jan Clerinx, * Alfons van Gompel, * Lut Lynen, * and Berten Ceulemans ([dagger])

* Institute of Tropical Medicine, Antwerp, Belgium; and ([dagger]) University Hospital Antwerp, Edegem, Belgium

Address for correspondence: Jan Clerinx, Institute of Tropical Medicine, Nationalestraat 155, B-2000 Antwerp, Belgium; email: jclerinx@itg.be
Table. Evolution of acute neuroschistosomiasis in 12-year-old boy
after treatment

Parameter Day 0 Day 45

Neurologic symptoms Present Present but diminished
Eosinophil count
 (per [mm.sup.3]) 3,080 1,030
Schistosoma ELISA Weakly positive Weakly positive
Schistosoma indirect
 hemagglutination
 assay (antibody titer) Negative 640
Urine microscopic analysis Normal Not available
Urine concentration test for
 schistosomal eggs Not available Not available
Feces concentration test for
 schistosomal eggs Not available Not available

Parameter Month 10

Neurologic symptoms Absent
Eosinophil count
 (per [mm.sup.3]) 370
Schistosoma ELISA Negative
Schistosoma indirect
 hemagglutination
 assay (antibody titer) 80
Urine microscopic analysis Normal
Urine concentration test for
 schistosomal eggs Negative
Feces concentration test for
 schistosomal eggs Negative
COPYRIGHT 2006 U.S. National Center for Infectious Diseases
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:LETTERS
Author:Ceulemans, Berten
Publication:Emerging Infectious Diseases
Article Type:Letter to the editor
Geographic Code:1USA
Date:Sep 1, 2006
Words:1255
Previous Article:Spring scrub typhus, people's Republic of China.
Next Article:Murine typhus from Vietnam, imported into Japan.
Topics:


Related Articles
Kluver-Bucy syndrome as a result of minor head trauma. (Letters to the Editor).
LETTERS IN THE EDITOR'S MAILBAG.
Teaching Math to People with Down Syndrome.
Jesse S. Crisler, Robert C. Leitz III, and Joseph R. McElrath, Jr. An Exemplary Citizen: Letters of Charles W. Chesnutt, 1906-1932.
Splitting with Eleventh Circuit, Seventh Circuit affirms debtors' rights.
LETTERS IN THE EDITOR'S MAILBAG.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters